Related posts:

1. Teva Respiratory Announces Positive Results From Phase III Trial Of BDP HFA Nasal Aerosol In Seasonal Allergic Rhinitis Teva Respiratory announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy endpoints, demonstrating a statistically significant benefit as compared to a placebo....
2. Organizations Highlight Plight Of HIV-Positive Haitians, Call For Donors To Support ‘Whole Of Society’ Health System Strengthening Organizations attending the International AIDS Conference-AIDS 2010 highlighted the plight of HIV-positive earthquake survivors in Haiti who are “still waiting for aid promised to them before” the quake as rebuilding efforts slowly move along, Agence France-Presse reports. AFP notes the sentiments of some of the organizations’ representatives…...
3. Share of Cost, UF Receives $4.7 Million To Study Marijuana’s Role In Immunity Among HIV-positive Adolescents HIV experts at the University of Florida, along with colleagues at the University of South Florida and the University of California, San Diego, have been awarded $4.7 million by the National Institutes of Health to study how the complex interplay between marijuana use and HIV infection can influence the development of neurological disorders in adolescents....
4. First Study Of Resiliency On The Battlefield Led By MSU First Study Of Resiliency On The Battlefield Led By MSU...
5. How do insurance companies set prices for Medigap policies? How do insurance companies set prices for Medigap policies?...
6. Seaside Therapeutics Initiates Phase 2b Study Of STX209 In Autism Spectrum Disorders Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 2b study to evaluate the effects of STX209 (arbaclofen) on social impairment in children, adolescents and adults (ages 5 to 21) with autism spectrum disorders (ASD). The Company announced positive results from an open-label Phase 2a study of STX209 in September of […]...
7. Developing Physician Communication Skills For Patient-Centered Care Growing enthusiasm about patient-centered medical homes, fueled by the Patient Protection and Affordable Care Act’s emphasis on improved primary care, has intensified interest in how to deliver patient-centered care. Essential to the delivery of such care are patient-centered communication skills. These skills have a positive impact on patient satisfaction, treatment adherence, and self-management. They can […]...